Lanzkron S - Search Results

1

A preliminary study of psychiatric, familial, and medical characteristics of high-utilizing sickle cell disease patients.

Carroll PC, Haywood C Jr, Hoot MR, Lanzkron S. Carroll PC, et al. Among authors: lanzkron s. Clin J Pain. 2013 Apr;29(4):317-23. doi: 10.1097/AJP.0b013e3182579b87. Clin J Pain. 2013. PMID: 23246997 Free PMC article.

2

Hospitalization rates and costs of care of patients with sickle-cell anemia in the state of Maryland in the era of hydroxyurea.

Lanzkron S, Haywood C Jr, Segal JB, Dover GJ. Lanzkron S, et al. Am J Hematol. 2006 Dec;81(12):927-32. doi: 10.1002/ajh.20703. Am J Hematol. 2006. PMID: 16924648 Free article.

3

Hydroxyurea for the treatment of sickle cell disease.

Segal JB, Strouse JJ, Beach MC, Haywood C, Witkop C, Park H, Wilson RF, Bass EB, Lanzkron S. Segal JB, et al. Among authors: lanzkron s. Evid Rep Technol Assess (Full Rep). 2008 Mar;(165):1-95. Evid Rep Technol Assess (Full Rep). 2008. PMID: 18457478 Free PMC article. Review.

4

Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease.

Lanzkron S, Strouse JJ, Wilson R, Beach MC, Haywood C, Park H, Witkop C, Bass EB, Segal JB. Lanzkron S, et al. Ann Intern Med. 2008 Jun 17;148(12):939-55. doi: 10.7326/0003-4819-148-12-200806170-00221. Epub 2008 May 5. Ann Intern Med. 2008. PMID: 18458272 Free PMC article. Review.

5

Provider barriers to hydroxyurea use in adults with sickle cell disease: a survey of the Sickle Cell Disease Adult Provider Network.

Lanzkron S, Haywood C Jr, Hassell KL, Rand C. Lanzkron S, et al. J Natl Med Assoc. 2008 Aug;100(8):968-73. J Natl Med Assoc. 2008. PMID: 18717150

6

Hydroxyurea for sickle cell disease: a systematic review for efficacy and toxicity in children.

Strouse JJ, Lanzkron S, Beach MC, Haywood C, Park H, Witkop C, Wilson RF, Bass EB, Segal JB. Strouse JJ, et al. Among authors: lanzkron s. Pediatrics. 2008 Dec;122(6):1332-42. doi: 10.1542/peds.2008-0441. Pediatrics. 2008. PMID: 19047254 Review.

7

Health care provider attitudes toward patients with acute vaso-occlusive crisis due to sickle cell disease: development of a scale.

Ratanawongsa N, Haywood C Jr, Bediako SM, Lattimer L, Lanzkron S, Hill PM, Powe NR, Beach MC. Ratanawongsa N, et al. Among authors: lanzkron s. Patient Educ Couns. 2009 Aug;76(2):272-8. doi: 10.1016/j.pec.2009.01.007. Epub 2009 Feb 23. Patient Educ Couns. 2009. PMID: 19233587 Free PMC article.

8

The excess burden of stroke in hospitalized adults with sickle cell disease.

Strouse JJ, Jordan LC, Lanzkron S, Casella JF. Strouse JJ, et al. Among authors: lanzkron s. Am J Hematol. 2009 Sep;84(9):548-52. doi: 10.1002/ajh.21476. Am J Hematol. 2009. PMID: 19623672 Free PMC article.

9

The course and correlates of high hospital utilization in sickle cell disease: Evidence from a large, urban Medicaid managed care organization.

Carroll CP, Haywood C Jr, Fagan P, Lanzkron S. Carroll CP, et al. Among authors: lanzkron s. Am J Hematol. 2009 Oct;84(10):666-70. doi: 10.1002/ajh.21515. Am J Hematol. 2009. PMID: 19743465 Free PMC article.

10

A systematic review of barriers and interventions to improve appropriate use of therapies for sickle cell disease.

Haywood C Jr, Beach MC, Lanzkron S, Strouse JJ, Wilson R, Park H, Witkop C, Bass EB, Segal JB. Haywood C Jr, et al. Among authors: lanzkron s. J Natl Med Assoc. 2009 Oct;101(10):1022-33. doi: 10.1016/s0027-9684(15)31069-5. J Natl Med Assoc. 2009. PMID: 19860302 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

185 results

Search Page

Filters